🌟𝐒𝐞𝐚𝐬𝐨𝐧’𝐬 𝐆𝐫𝐞𝐞𝐭𝐢𝐧𝐠𝐬 𝐟𝐫𝐨𝐦 𝐂𝐚𝐦𝐮𝐫𝐮𝐬!🌟 2024 was a remarkable year, in which we: 💙Enhanced access to opioid dependence treatments across our markets 🌐Sponsored and participated in numerous key international and national meetings 🎉Opened our first US office in Princeton, New Jersey, welcoming our first US colleagues 📢Supported disease awareness initiatives to promote equitable care and reduce stigma 🏢Prepared the move to our new headquarters in The Loop, Science Village, Lund, Sweden 🌱 Strengthened our sustainability efforts, setting long-term goals for renewable energy and aiming for climate neutrality by 2045 … and much more. In line with our commitment to community and environmental support, this year’s Christmas gift to Camurus employees is a donation of 100,000 SEK to the United Nations Refugee Agency (UNHCR) for their work in Ukraine. As we recharge for the new year, we remain committed to improving the lives of patients with severe and chronic diseases. Thank you to all our stakeholders. We look forward to continuing our valuable collaborations in 2025! For more information about what drives us, visit: https://www.camurus.com/ #TogetherWeAreCamurus
Camurus
Tillverkning av läkemedel
Lund, Skåne 8 313 följare
Committed to developing and commercializing long-acting treatments for patients with severe and chronic diseases.
Om oss
Camurus is a Swedish science-led biopharmaceutical company committed to improving the lives of patients with severe and chronic diseases. We empower patients, support caregivers and create value for society by developing and giving access to innovative, long-acting medicines. To fulfill our commitment, we are determined to conduct our business in a sustainable manner. New drug products with best-in-class potential are conceived based on the company's proprietary FluidCrystal® technology and extensive R&D expertise. Camurus’ clinical pipeline includes products for the treatment of treatment of opioid dependence, cancer, and endocrine disorders, which are developed in-house and in collaboration with international pharmaceutical companies. The company’s shares are listed on Nasdaq Stockholm under the ticker CAMX.
- Webbplats
-
http://www.camurus.com
Extern länk för Camurus
- Bransch
- Tillverkning av läkemedel
- Företagsstorlek
- 201–500 anställda
- Huvudkontor
- Lund, Skåne
- Typ
- Publikt aktiebolag
- Grundat
- 1991
- Specialistområden
- Drug formulation technologies, Development and commercialization of innovative specialty medicines, Pharmaceutical research, Drug delivery systems, Opioid dependence treatment, Lipid phase nanostructures och Rare diseases
Adresser
-
Primär
Ideon Science Park
Lund, Skåne 223 70, SE
Anställda på Camurus
Uppdateringar
-
Greetings from Berlin! Camurus is excited to participate in the DGPPN Congress, taking place 27-30 November at the CityCube in Berlin, Germany. The meeting – organized by the German Association for Psychiatry, Psychotherapy, Psychosomatics, and Neurology – is Europe’s largest congress in the field of mental health, attracting more than 9,000 physicians, researchers, therapists, and healthcare professionals. This year’s theme, “Mental Health in Times of Crisis,” highlights critical topics such as recent scientific advancements, clinical practice insights in prevention, diagnostics, and therapy, as well as health policy, societal, and cultural discussions. It also emphasizes the growing awareness of the crucial link between mental health disorders and the development of opioid dependence, one of Camurus’ key therapeutic areas. Early identification and treatment of these co-occurring conditions are essential for improving treatment outcomes. The Camurus team is present with a booth and looking forward to four inspiring days of valuable networking and knowledge sharing! Learn more about the DGPPN Congress: https://lnkd.in/d_jDbqgK dgppn - Deutsche Gesellschaft für Psychiatrie und Psychotherapie, Psychosomatik und Nervenheilkunde #Camurus #Conference #DGPPN2024
-
📣 For investors and media: Join us for an exciting update from Camurus! Our President and CEO, Fredrik Tiberg, will be presenting at the Jefferies London Healthcare Conference 2024 on Camurus' latest developments and progress. 🗓️ Date: Wednesday, 20 November 🕜 Time: 1:30 pm GMT 📺 Watch presentation: https://lnkd.in/dy-wU_zD The Jefferies London Healthcare Conference is the largest healthcare-dedicated conference in Europe, bringing together leading global companies and investors to discuss the latest trends and opportunities in the healthcare sector. #Camurus #Conferences #LifeScience #HealthcareInnovations #JefferiesHealthcare
-
The Camurus Australia team is excited to be on-site at the GPCE (General Practice Conference & Exhibition) conference, happening at the Melbourne Convention & Exhibition Centre from 15-17 November. This esteemed event attracts over 1,200 healthcare professionals, including General Practitioners (GPs) from across Australia. 📅 Camurus is sponsoring a session on Sunday 17 November at 2.45 pm local time (AEDT) around recent changes in Australia to the opioid dependence treatment program, and the implications for general practice. If you are attending the conference, pass by the Camurus stand to connect with our team! For more information see: https://lnkd.in/gKNKtC7j #HealthcareInnovation #Camurus #Conference #GPCEMelbourne #GPCE
-
🌍 Embracing Sustainability at Camurus! On Friday 8 November, we had the pleasure of welcoming almost 30 students from Deakin University in Australia, alongside participants from Lund’s School of Economics and Management to Camurus’ headquarters in Lund, Sweden. Focus was sustainability within business – a topic embedded in Camurus’ commitment. Camurus’ Chief Technical Officer Torsten Malmström kicked off the session with an introduction to Camurus, followed by a presentation by Iris Rehnström, our Director of Sustainability, who shared insights and learnings around challenges and opportunities, highlighting the importance of sustainability throughout our value chains. Thank you to all the students and participants for your enthusiasm, smart questions and engaging conversation! Learn more about our sustainability journey: https://lnkd.in/ekKheiJZ #Sustainability #Business #Pharmaceuticals #Camurus #DeakinUniversity #LundUniversity #SustainableFuture
-
Yesterday 10 November was World NET Cancer Day! Camurus is honored to be part of and support this awareness campaign – coordinated by the International Neuroendocrine Cancer Alliance (INCA) – which aims to raise a voice for those affected by any type of neuroendocrine tumors (NETs). Its mission is to increase knowledge, secure timely diagnosis, and access to optimal care. NETs are slow-growing cancerous tumors originating from cells in the endocrine and nervous systems that can occur throughout the body. The disease is life-limiting and is often diagnosed late in disease progression. Gastroenteropancreatic neuroendocrine tumors, GEP-NET, is the most common subgroup of NETs with tumors located in the gastrointestinal tract or pancreas. (1) Though relatively rare, NETs are more prevalent than brain, ovarian, and cervical cancer, and the incidence is rising, making symptom awareness vital for earlier diagnosis and ultimately better outcomes. (2) In connection to the day, Camurus’ employees will this week learn more by listening to Simona Barbi – INCA Secretary of the Board and President of NET Italy presenting on NETs from a patient perspective. We are looking forward to it! Learn more about NETs by watching the video 👇 and on: https://lnkd.in/dy4DZBTq 1. Das, S., et al. Current Oncology Reports. Mar 14; 23(4): 43, 2021; 2. INCA.org #NETCancerDay #Camurus #Diseaseawareness #LetsTalkAboutNETs
-
🌟Last night, 7 November, Camurus Australia, represented by Ruari Macdonald, General Manager, Lisa Bubb, Head of Medical Affairs and Polly Kingsmill, Head of Marketing, attended the 20th annual PRIME awards in Sydney. The PRIME Awards is an awards program designed to recognize and reward true excellence within healthcare communications in Australia. Camurus alongside the partner Elbow Insight and Strategy were selected as finalists in the category ‘Best use of data or Insights’, with our submission: Breaking the chains of opioid dependency – a narrative illustrating how individuals, despite facing profound stigma and immense challenges, find the courage to seek help and embark on a journey of recovery. We are incredibly proud to see Camurus selected as one of the finalists and in particularly the recognition of our work to generate actionable insights to disrupt the treatment landscape in Australia and offer Australian people with opioid dependence more options in their recovery journey. A huge congratulations to the winners in all categories! 🎉 See list of finalists: https://lnkd.in/gHXUZbVn
-
📣For investors and media: Today we publish our Interim Report for the third quarter 2024! Financial analysts and media are invited to attend a telephone conference and presentation of the results today at 2 pm (CET). Learn more and see full press release 7 November 2024: https://lnkd.in/enVbpZvw
-
Our Camurus Australia team is thrilled to be sponsoring and be on-site at the Australian College of Nurse Practitioners (ACNP) National Conference taking place 6-8 November in Cains. This year’s theme, “Beyond Today. Sustaining Australian Healthcare,” is truly resonating as the team connects with the over 500+ nurse practitioners and healthcare leaders from across Australia attending the meeting. If you are attending, make sure to connect with our team! Learn more on the conference website: https://lnkd.in/gcQPnuyg #ACNP2024 #NursePractitioners #HealthcareInnovation #Camurus #Conferences
-
Camurus’ team – Fredrik Joabsson, Chief Business Development Officer, Linn Antberg, Director Business Development & Alliance Management and Maria Sörhede Winzell, Senior Director Drug Development Strategy & Innovation – are on spot at #BIOEurope 2024 and thrilled to be connecting with industry leaders, exploring latest innovations and interact in conversations on the future of healthcare. BIO Europe, this year taking place 4-6 November in Stockholm, Sweden, is considered Europe’s largest life sciences partnering event bringing together over 5,500 delegates representing more than 2,800 companies. At Camurus, we are continuously looking for new partnership opportunities with the aim to bring transformational therapies to the people who needs them. Learn more about us and partnering on our website: https://www.camurus.com/ #Camurus #BIOEUROPE #Conferences #Networking #Partnering #BusinessDevelopment #lifescience
Liknande sidor
Finansiering
Senaste finansieringsrunda
Okänd serie57 430 129,00 US$